De sprekers die (onder voorbehoud) acte de présence zullen geven op
de internationale Invest in ME-konferentie 20 mei 2011 in Londen, zijn:
Nadere informatie over deze konferentie (onderwerpen, etc.) volgt hopelijk binnenkort.
The 6th Invest in ME International ME/CFS Conference 2011
The Way Forward for ME - A Case for Clinical Trials
Invest in ME are pleased to announce the following speakers at the conference:
Dr. David Bell MD
Dr. David Bell graduated from Harvard College and gained an MD degree at Boston University.
Post doctoral training in paediatrics was completed with subspecialty training in Paediatric Behavior and Developmental Disorders.
In 1978 he began work at the University of Rochester and then began a private practice in the town of Lyndonville, New York.
In 1985 nearly 220 persons became ill with an illness subsequently called chronic fatigue syndrome in the communities surrounding Lyndonville, New York.
This illness cluster began a study of the illness which continues today.
Dr. David Bell is the author or co-author of numerous scientific papers on CFS, and,
in 2003 was named Chairman of the Advisory Committee for Chronic Fatigue Syndrome of the Department of Health and Human Services.
Publications include A Disease of A Thousand Names, (1988) and The Doctor's Guide to Chronic Fatigue Syndrome, (1990).
Dr. Bell is currently performing ME/CFS research into the XMRV retrovirus.
Mrs. Annette Whittemore
Founder and President of the Whittemore Peterson Institute for Neuroimmune Diseases, Reno, Nevada, USA.
The Institute is located on the medical campus of the University of Nevada.
Its mission is to serve those with complex neuro-immune diseases such as ME/CFS, viral induced central nervous system dysfunction and fibromyalgia.
Annette Whittemore graduated in Elementary and Special Education at the University of Nevada and
taught children with neuro-cognitive deficits, such as those found in autism, ADD, and learning disabilities.
As the president and director of the current operations at the Institute Annette supports the basic and clinical research program,
and actively recruits physicians and other support personnel for the Institute.
Dr. Judy Mikovits PhD
Judy Mikovits is Research Director at the Whittemore Peterson Institute for Neuro-Immune Diseases and
has co-authored over 40 peer reviewed publications that address fundamental issues of viral pathogenesis, hematopoiesis and cytokine biology.
Formally trained as a cell biologist, molecular biologist and virologist,
Dr. Mikovits has studied the immune response to retroviruses and herpes viruses including HIV, SIV, HTLVI, HERV, HHV6 and HHV8
with a special emphasis on virus host cell interactions in cells of the hematopoietic system including hematopoietic stem cells (HSC).
Dr Mikovits is one of the authors of the ground-breaking study published in Science magazine in October 2009
which detected XMRV in CFS patients (Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome) and
is a member of the US Department of Health and Human Services Blood Working Group.
Professor Kenny De Meirleir MD, PhD
Professor De Meirleir is a world renowned researcher of ME/CFS.
He is full professor of physiology, pathophysiology and medicine at the Vrije Universiteit Brussel and
practices Internal Medicine at Himmunitas Foundation also in Brussels and
has published several hundred peer reviewed articles and
is co-author of the book 'Chronic Fatigue Syndrome: a biological approach' and
was co-editor of the Journal of Chronic Fatigue Syndrome, and
reviewer for more than 10 other medical journals.
Professor De Meirleir was one of four international experts on the panel that developed the Canadian Consensus Document for ME/CFS.
He assesses/treats thousands of ME/CFS patients annually and is the most experienced researcher in Europe regarding ME/CFS.
His research activities in ME/CFS date back to 1990.
His other research activities in exercise physiology, metabolism and endocrinology have led to the Solvay Prize and the NATO research award.
Dr. Jose Montoya MD
Associate Professor of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, California, USA and
Director, Toxoplasmosis National Reference Laboratory at Palo Alto Medical Foundation, California, USA.
He completed his residency in Internal Medicine at Tulane University.
Dr Montoya then completed his post-doctoral fellowship at Stanford University.
Currently, he is serving as an associate professor in Infectious Diseases at Stanford.
He has worked on a wide variety of projects in this field including research focused on the efficacy of new smallpox vaccines.
Additionally, he is the founder and co-director of the Immunocompromised Host Service and works at the Positive Care Clinic at Stanford.
Dr. Montoya specializes in toxoplasmosis and infectious diseases particularly as it pertains to cardiac transplants and AIDS patients.
Dr. Montoya is also the recipient of many Stanford teaching awards, including the Bloomfield, Ebaugh, Kaiser and Rytand awards.
Currently Stanford University is taking a very active role in
the study of patients with unexplained chronic illnesses such as chronic Lyme disease, chronic fatigue syndrome and multiple sclerosis.
Dr. John Chia MD
Dr Chia is an infectious disease specialist, Torrance, California, USA.
He has published research ("Chronic fatigue syndrome associated with chronic enterovirus infection of the stomach")
on the role of enteroviruses in the aetiology of ME/CFS - an area which has been implicated as one of the causes by a number of studies.
There are more than 70 different types of enteroviruses that can affect the central nervous system, heart and muscles, all of which is consistent with the symptoms of ME/CFS.
By analyzing samples of stomach tissue from 165 patients with CFS,
Dr. Chia's team discovered that 82% of these individuals had high levels of enteroviruses in their digestive systems.
Dr Chia's research may result in the development of antiviral drugs to treat the debilitating symptoms of ME/CFS.
Professor Olav Mella MD, PhD and/or Dr Řystein Fluge MD, PhD (tbc)
from the Institute of Medicine, Section of Oncology, University of Bergen, Norway and
Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Professor Mella and Dr Fluge have performed clinical trials to test the benefit of B-cell depletion therapy using Rituximab in ME/CFS patients.